Protara Therapeutics Inc. (TARA) Statistics & Valuation Metrics - Stocknear

Protara Therapeutics Inc.

NASDAQ: TARA · Real-Time Price · USD
3.15
-0.02 (-0.63%)
At close: Sep 05, 2025, 3:59 PM
3.01
-4.30%
After-hours: Sep 05, 2025, 05:42 PM EDT

Protara Therapeutics Statistics

Share Statistics

Protara Therapeutics has 38.58M shares outstanding. The number of shares has increased by 87.02% in one year.

38.58M
87.02%
4.93%
68.68%
33.99M
30
0.01%

Short Selling Information

The latest short interest is 2.77M, so 7.19% of the outstanding shares have been sold short.

2.77M
7.19%
7.37%
14.13

Valuation Ratios

The PE ratio is -2.44 and the forward PE ratio is -1.9. Protara Therapeutics's PEG ratio is 0.06.

-2.44
-1.9
0
5.4
0.65
-3.03
0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Protara Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 15.71, with a Debt / Equity ratio of 0.03.

15.71
15.71
0.03
-0.09
-0.12
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.59M
28
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 69.35% in the last 52 weeks. The beta is 1.51, so Protara Therapeutics's price volatility has been higher than the market average.

1.51
69.35%
3.12
3.83
50.17
290,096

Income Statement

n/a
-332K
-49.15M
-44.6M
-49.15M
-40.42M
-2.17
Full Income Statement

Balance Sheet

The company has 162.8M in cash and 4.48M in debt, giving a net cash position of 158.31M.

162.8M
4.48M
158.31M
-244.98M
156.93M
115.33M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -35.81M and capital expenditures -63K, giving a free cash flow of -35.87M.

-35.81M
-63K
-35.87M
-1.74
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

TARA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for TARA is $21, which is 566.7% higher than the current price. The consensus rating is "Buy".

$21
566.7%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Jan 10, 2020. It was a backward split with a ratio of 1:40.

Jan 10, 2020
backward
1:40

Scores

3.21
1